Skip to content
Diopsys logo — Helping eye care specialists detect dysfunction early, track...

Diopsys

Helping eye care specialists detect dysfunction early, track disease progression, and tailor treatment for each patient.

Founded 1998 United States Middletown, United States 29 employees Venture round Total: $1.05M Health Care, Medical Devices

General Information

Company Name Diopsys
Founded Year 1998
Location United States Middletown, United States
Employees 29
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Diopsys. To contact Diopsys, visit diopsys.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Diopsys compare?

A PDF of Diopsys and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Diopsys soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Diopsys

Diopsys is a health care and medical devices startup that aims to support eye care specialists in detecting dysfunction early, tracking disease progression, and tailoring treatment for each patient. Founded in 1998, the company provides eye care professionals with objective, functional information about the health of the vision system to aid in the early detection of vision disorders, and post-treatment tracking for enhanced patient management.

The startup recently received a significant boost with a $1.05M venture round investment on 17 October 2019. The investment underscores the potential of Diopsys and its innovative approach to revolutionizing vision care. With a focus on leveraging technology to improve patient outcomes, Diopsys presents a compelling opportunity for venture capitalists seeking to support advancements in the health care and medical devices industries.

As the company continues to make strides in its mission to provide valuable insights for eye care specialists, investors have the opportunity to contribute to the growth and success of a venture that is dedicated to enhancing the early detection and management of vision disorders. The recent investment demonstrates confidence in Diopsys' vision and capabilities, positioning the startup as a promising player in the evolving landscape of eye care technology.

Business keywords: Medical Instrumentation, Diagnostic Testing Equipment, Electrophysiology, Early Detection, Vision Testing, Visual Electrophysiology, Retina Function, Ophthalmic Care, Patient Management, Disease Progression, Treatment Tracking, Vision Disorders, Optometric Technology, Quality of Life Improvement

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $1.05M -
17 Oct 2019

Diopsys Alternatives & Competitors

View All Alternatives
Diopsys vs
Reyedar
Reyedar The Netherlands

Medtech startup that combines eye tracking and A.I. to provide fast, objective, and patient-friendly...

Seed
11 employees
Health Care, Manufacturing
Diopsys vs
iScreen Vision
iScreen Vision United States

Detect Early Vision Damage Risk in Children with Instrument-Based Vision Screening Technology & Spec...

Debt Financing
16 employees
Biotechnology, Health Care
Diopsys vs
Injectsense Inc.
Injectsense Inc. United States

Implantable Sensor-Enabled Digital Health

Convertible Note
13 employees
Biotechnology, Health Care

FAQ About Diopsys

Helping eye care specialists detect dysfunction early, track disease progression, and tailor treatment for each patient.
Diopsys was founded in 1998.
Diopsys is headquartered in Middletown, United States.
Diopsys operates in Health Care and Medical Devices. Its work centres on Medical Instrumentation, Diagnostic Testing Equipment, Electrophysiology and Early Detection.
Diopsys has approximately 29 employees.
Diopsys has completed 1 funding round, raising a total of $1.05M. The latest funding stage is Venture round.
Top alternatives and competitors to Diopsys include Reyedar, iScreen Vision, Injectsense Inc., Volk Optical Inc., Globus Medical. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Diopsys and Reyedar are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Diopsys, https://bouncewatch.com/company/diopsys, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout